1. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's disease
Sara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article

Keywords: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events
Full text (file, 411,70 KB) This document has more files! More...